A detailed history of Qsv Equity Investors LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Qsv Equity Investors LLC holds 135,539 shares of INVA stock, worth $2.62 Million. This represents 2.32% of its overall portfolio holdings.

Number of Shares
135,539
Previous 136,318 0.57%
Holding current value
$2.62 Million
Previous $2.08 Billion 7.0%
% of portfolio
2.32%
Previous 2.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$14.4 - $16.4 $11,217 - $12,775
-779 Reduced 0.57%
135,539 $2.22 Billion
Q1 2024

May 15, 2024

BUY
$14.56 - $16.78 $13,176 - $15,185
905 Added 0.67%
136,318 $2.08 Billion
Q4 2023

Feb 14, 2024

BUY
$12.32 - $16.27 $1.67 Million - $2.2 Million
135,413 New
135,413 $2.17 Billion

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.35B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Qsv Equity Investors LLC Portfolio

Follow Qsv Equity Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qsv Equity Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qsv Equity Investors LLC with notifications on news.